TTP and New England Biolabs (NEB) announce that they have established a non-exclusive partnership to offer services to molecular diagnostic technology developers. The new offering will include comprehensive product development services that span instrumentation, consumables and reagents.
The partnership is focused on supporting customers in the molecular diagnostic and wider life science space to rapidly transition ideas into commercially successful products. The services will couple NEB's catalog of reagents and expertise in enzyme development and manufacturing with TTP's Desktop Biology product development and physical engineering know-how, to provide capabilities that allow the delivery of more complete solutions, spanning from consumables and instrumentation through to reagents.
"With over 40 years of molecular biology expertise and the industry's largest selection of recombinant and native enzymes for genomic research, NEB is the ideal partner for our molecular diagnostics services. NEB reagents are mainstays of the modern molecular biology laboratory and are already essential components of many of today's diagnostic platform technologies,” Dr. Giles Sanders, Consultant at TTP, said. “At TTP, we understand the fundamental steps required to convert lab-based biological processes to a functional low-cost disposable and instrument, and together we now able to fast track more complete product development solutions."
NEB holds ISO13485 and ISO9001 Quality Management Systems certifications and is actively increasing capacity to manufacture enzymes and other reagents according to good manufacturing practices (GMP) for us in the human therapeutic and molecular diagnostic markets.